Cyclin K dependent regulation of Aurora B affects apoptosisand proliferation by induction of mitotic catastrophe inprostate cancer
Cyclin K plays a critical role in transcriptional regulation as well as cell development. However, the role of Cyclin K in prostatecancer is unknown. Here, we describe the impact of Cyclin K on prostate cancer cells and examine the clinical relevance ofCyclin K as a biomarker for patients with prost...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
3 July 2017
|
| In: |
International journal of cancer
Year: 2017, Jahrgang: 141, Heft: 8, Pages: 1643-1653 |
| ISSN: | 1097-0215 |
| DOI: | 10.1002/ijc.30864 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1002/ijc.30864
|
| Verfasserangaben: | Sabrina Schecher, Britta Walter, Michael Falkenstein, Stephan Macher-Goeppinger, Philipp Stenzel, Kristina Krümpelmann, Boris Hadaschik, Sven Perner, Glen Kristiansen, Stefan Duensing, Wilfried Roth and Katrin E. Tagscherer |
| Zusammenfassung: | Cyclin K plays a critical role in transcriptional regulation as well as cell development. However, the role of Cyclin K in prostatecancer is unknown. Here, we describe the impact of Cyclin K on prostate cancer cells and examine the clinical relevance ofCyclin K as a biomarker for patients with prostate cancer. We show that Cyclin K depletion in prostate cancer cells inducesapoptosis and inhibits proliferation accompanied by an accumulation of cells in the G2/M phase. Moreover, knockdown ofCyclin K causes mitotic catastrophe displayed by multinucleation and spindle multipolarity. Furthermore, we demonstrate aCyclin K dependent regulation of the mitotic kinase Aurora B and provide evidence for an Aurora B dependent induction ofmitotic catastrophe. In addition, we show that Cyclin K expression is associated with poor biochemical recurrence-free survivalin patients with prostate cancer treated with an adjuvant therapy. In conclusion, targeting Cyclin K represents a novel, promis-ing anti-cancer strategy to induce cell cycle arrest and apoptotic cell death through induction of mitotic catastrophe in pros-tate cancer cells. Moreover, our results indicate that Cyclin K is a putative predictive biomarker for clinical outcome andtherapy response for patients with prostate cancer. |
|---|---|
| Beschreibung: | Gesehen am 17.04.2018 |
| Beschreibung: | Online Resource |
| ISSN: | 1097-0215 |
| DOI: | 10.1002/ijc.30864 |